Abstract
Background
In contrast to dogs, the causes and outcomes of urinary incontinence (UI) in cats are largely unknown.
Objectives
To determine the causes, identify comorbid conditions, and assess outcomes of cats with micturition disorders presenting as UI.
Animals
Forty‐five cats with UI.
Methods
Retrospective study. Medical records of cats presented from January 2006 to December 2017 were searched using 45 keywords related to UI. History, presenting complaint, and physical examination findings were used to confirm a diagnosis. Cases were categorized based on functional and anatomic localizations.
Results
Forty‐five cats met inclusion criteria. Spinal cord disease was the most common cause of UI (n = 18), followed by urethral (n = 17), bladder (n = 9), and ureteral (n = 1) disorders. Proportions of voiding and storage phase disorders were similar (53% and 47%, respectively). However, voiding‐phase disorders were observed more frequently in males and younger‐aged cats (P < .03). Urinary tract infection was detected in 11 of 28 (39%) cats. Outcomes were available in 38/45 cases; 16 cats (42%) regained continence, 3 (8%) improved with treatment, and 19 (50%) remained incontinent or were euthanized. Multiple variable logistic regressions indicated that spinal cord disease was significantly more likely to be associated with poor outcomes compared to bladder or urethral disorders (P < .04).
Conclusions and Clinical Importance
Urinary incontinence in cats was associated with a variety of congenital and acquired disorders that affected both phases of micturition with similar frequency. Incontinent cats with spinal cord disorders were common and warrant a more guarded prognosis than do cats with bladder or urethral disorders.
Keywords: bladder, ectopic ureter, FIC, spinal cord disease, ureter, urethra, urethral sphincter mechanism incompetence, urinary tract infection
Abbreviations
- FeLV
feline leukemia virus
- FIC
feline idiopathic cystitis
- IQR
interquartile range
- IVDD
intervertebral disk disease
- UI
urinary incontinence
- USMI
urethral sphincter mechanism incontinence
- UTI
urinary tract infection
1. INTRODUCTION
Urinary incontinence (UI) is encountered uncommonly in cats,1, 2 and clinical observations indicate that the frequency and causes of UI in cats are considerably different from those of dogs. In dogs, UI is the second most common lower urinary tract disease accounting for 24% of affected dogs.3 Of these, storage phase micturition disorders such as acquired urethral sphincter mechanism incontinence (USMI) or ureteral ectopia accounted for most cases.1, 3 In cats, however, the proportional morbidity of UI as a cause of lower urinary tract disease is considerably lower.2, 4 In a survey of 24 veterinary teaching hospitals, UI accounted for only 4% of lower urinary tract disease diagnosed in cats over a 17‐year period.2 In another survey of lower urinary tract disorders in 81 geriatric cats, UI was diagnosed in only 5% of affected cats.4
Urinary incontinence in cats has been associated with over 43 congenital or acquired disorders affecting the spinal cord,5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 urinary bladder,20, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38 urethra,20, 28, 29, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50 or reproductive tract.51, 52, 53 However, descriptions of disorders associated with UI in cats often have been limited to anecdotal case reports or selected case series. In a review of 19 cats with congenital UI, 10 cats had ureteral ectopia and 9 had congenital USMI.20 In another series of 11 cats with acquired UI not associated with pelvic trauma, all affected cats had an idiopathic storage phase disorders, with 9 of 9 cats testing positive for feline leukemia virus (FeLV).54 Larger and more comprehensive comparative studies of proportional morbidity of causes, clinical features, and outcome assessments of cats with UI have not been reported. Design of rational diagnostic approaches, selection of effective treatment strategies, and formulation of more accurate prognoses for cats with UI would be facilitated by more comprehensive knowledge of relative frequency of causes, clinical features, and outcomes. The purpose of our study was to determine the proportional morbidity of causes, characterize the clinical features, and assess outcomes of cats presented to a veterinary medical referral center for evaluation of UI over an 11‐year period.
2. MATERIALS AND METHODS
2.1. Cases
Medical records of cats presented to the Michigan State University Veterinary Medical Center from 2006 to 2017 were searched electronically using 45 keywords related to abnormalities of micturition (see Data S1, Supplemental Information). Urinary incontinence was defined as any involuntary leakage of urine.55, 56, 57, 58, 59 Cats were included if they had a presumptive diagnosis of UI based on owner observations of involuntary urine leakage (eg, dribbling, leaking, or soiling of bedding or owner's clothing while resting; involuntary hemorrhagic urine discharge) or observed involuntary urine dribbling or leaking on physical examination. Cats without UI and only owner‐reported sign of voluntary micturition patterns such as polyuria, pollakiuria, or inappropriate behavioral urination were excluded. Cats with insufficient information to establish a presumptive diagnosis of UI were excluded. Additional follow‐up information, when available, was obtained from referring veterinarians or owners by phone or email.
2.2. Data collection
Data were collected retrospectively and tabulated in an electronic spreadsheet (Microsoft Excel 2016 16.0.67.2048, Microsoft Corp., Redmond, Washington) Data collected included sex, neuter status, breed, weight, date of birth, age at presentation, duration of clinical signs, physical examination findings (including bladder size), results of clinicopathologic, microbiologic, and diagnostic imaging evaluations, treatment, comorbid conditions, and outcomes. Urinary tract infection (UTI) was defined as isolation of >1 × 103 colony‐forming units (cfu)/ml urine in samples collected by cystocentesis or urinary catheterization.
2.3. Data analysis
Cats were classified into functional groups by phase of micturition (voiding‐phase or storage‐phase disorders) based on physical examination or diagnostic imaging findings indicating a large, distended bladder (voiding phase disorder) versus a small bladder (storage phase disorder).56, 57, 58, 59 Cats also were classified into anatomic groups (spinal cord, bladder, ureteral, or urethral disorders) based on lesion localization.58 Underlying causes were identified with as much specificity as possible for each cat based on history, physical examination findings, and results of clinicopathologic testing and diagnostic imaging. Cats with UI that coincided with an inflammatory lower urinary tract condition and that was characterized as a storage phase disorder associated with a small bladder and other lower urinary tract signs (eg, pollakiuria, stranguria, periuria) were classified as “inflammation‐associated detrusor dysfunction.” Outcomes were considered “favorable” if incontinence resolved or improved with treatment. Outcomes were considered “unfavorable” if UI did not response to treatment, or if cats were euthanized for causes related to their incontinence or comorbid diseases (eg, trauma). For univariable analyses, categorical data were compared using Fisher's exact test or Chi‐squared analysis. Continuous data were assessed for normality using the Shapiro‐Wilk test. Normally distributed results were compared using a Student's t test. Data that were not normally distributed were compared using a Mann‐Whitney U test or Kruskal‐Wallis 1‐way ANOVA. Univariable analyses were performed using a statistical software package (SigmaStat 4.0, Systat Software, Inc., Point Richmond California) with a 0.05 type I error for significance. To evaluate the association of major risk factors on outcome, a multiple variable logistic regression modeling approach was used. The analysis was conducted in 2 stages. First, major risk factors hypothesized to influence outcome (favorable or unfavorable) were analyzed using the stepwise‐backward approach. Risk factors included: (1) age group at the time of onset (juvenile, 0‐6 months; young adult, 7‐78 months; mature adult, 79‐174 months; and geriatric, >174 months),60 (2) anatomic site (spinal cord, urethra, and bladder), (3) micturition phase (voiding or storage phase), (4) presence of other neurological signs (yes or no), (5) presence of UTI (yes or no), and (6) treatment (surgical and medical management, or medical management alone). Results of the first analysis evaluating major risk factors indicated that anatomic site was the only factor that significantly influenced outcome. Accordingly, the second analysis was aimed at identifying which of the anatomic sites had the greatest influence on outcome. Multivariable statistical analyses were performed using a statistical software package (JMP Pro 13.0.0, SAS Institute Inc., Cary, North Carolina) with 0.05 type I error for significance.
3. RESULTS
Forty‐five of 22 646 (0.17%) cats reviewed during the study period met inclusion criteria and included 22 spayed females, 22 castrated males, and 1 intact male cat. The overall median age of affected cats was 54 months (interquartile range [IQR], 21‐144). The age distribution of affected cats was bimodal with 28 (62%) cats ≤5 years of age and 11 (25%) cats ≥12 years of age. Forty‐one (91%) cats were mixed breed; 4 purebred cats included American Shorthair (1), Manx (2), and Turkish Van (1) breeds.
Causes of UI included congenital, acquired, and iatrogenic lesions of the spinal cord, ureters, bladder, and urethra (Table 1). The proportion of cats with voiding phase disorders (24/45, 53%) was similar to that of cats with storage phase disorders (21/45, 47%). When classified by anatomic localization, the most common site of disease was spinal cord (18/45, 40%), followed by urethra (17/45, 38%), bladder (9/45, 20%), and ureter (1/45, 2%). The most common pathophysiologic etiologies of UI were spinal cord trauma (9/45, 20%), congenital anomalies (8/45, 18%), urethral stricture (6/45, 13%), and inflammation‐associated detrusor dysfunction (6/45, 13%). Congenital causes of UI were identified in 8/45 (18%) cats and included spinal canal malformations (4), congenital USMI (2), urethral hypoplasia (1), and bilateral ureteral ectopia (1). Incontinence was associated with iatrogenic causes in 10/45 (22%) cats and involved complications associated with perineal urethrostomy (5), urethral catheterization (2), and placement of urethral or ureteral stents (3). Overall, bacterial UTI was identified in 11 of 28 (39%) cats in which urine culture results were available. Other comorbid conditions included urine scalding, loss of tail tone or sensation, caudal paresis or paralysis, fecal incontinence, muscle atrophy, multiple trauma, and constipation. One or more additional neurological signs (loss of tail tone or sensation, caudal paresis or paralysis, or fecal incontinence) were reported in 16 of 45 (36%) cats.
Table 1.
Causes of urinary incontinence in 45 cats grouped by phase of micturition affected and anatomic localization. Number in parentheses indicates number of cats
| Micturition phase | Anatomic localization | Specific disorder |
|---|---|---|
| Voiding phase disorders (24) | Spinal cord (15) |
Trauma (8) Cauda equina syndrome (7) Fracture/luxation (1) Neoplasia, undetermined (2) IVDD (2) Fibrocartilaginous emboli (1) Spinal dysraphism (1) Sacral malformation (1) |
| Bladder (2) | Detrusor dysfunction, undetermined (2) | |
| Urethra (7) |
FIC/urethritis (1) Urethral stricture (6) Post‐perineal urethrostomy (4) Post‐urethral catheterization (1) Idiopathic stricture (1) |
|
| Storage phase disorders (21) | Spinal cord (3) |
Spinal dysraphism (Manx cat) (1) L7 lumbar spine malformation (1) Trauma, cauda equina syndrome (1) |
| Ureter (1) | Bilateral ectopic ureters (1) | |
| Bladder (7) |
Neoplasia, transitional cell carcinoma (1) Inflammation‐associated detrusor dysfunction (presumed urge incontinence) (6) FIC (3) UTI (2) Ureteral stent + SUB + UTI (1) |
|
| Urethra (10) |
Urethral mass + urethral stent (2) Prostatic adenocarcinoma (1) Epithelial hyperplasia (1) Urethritis, post‐urethral catheterization (1) Congenital urethral hypoplasia (1) Congenital USMI (2) Acquired USMI (1) Post‐perineal urethrostomy (1) Urethral dysfunction, undetermined (2) |
Abbreviations: FIC, feline idiopathic cystitis; IVDD, intervertebral disk disease; USMI, urethral sphincter mechanism incompetence; UTI, urinary tract infection.
When compared by functional classification (voiding versus storage phase of micturition), univariate analyses indicated that voiding phase disorders were significantly more common in male cats, whereas storage phase disorders were more common in female cats (Table 2; P < .03). Cats with voiding phase disorders were significantly younger than those with storage phase disorders (Table 2; P < .05) and were observed most commonly in the young adult age group (Figure 1). Although median serum creatinine concentration was significantly higher in cats with storage phase compared to voiding phase disorders (Table 2; P < .01), both values were within the normal reference interval. The proportion of voiding phase disorder cats with additional neurologic signs (loss of tail tone or sensation, caudal paresis or paralysis, or fecal incontinence) was significantly higher than storage phase disorder cats (P < .01). No significant differences were found between functional groups for breed, body weight, duration of clinical signs, and other serum biochemistry, urinalysis, or urine culture results.
Table 2.
Demographic features, clinicopathologic findings, and clinical outcomes for 45 cats with urinary incontinence classified by phase of micturition affected
| Feature | Voiding phase disorders | Storage phase disorders | P |
|---|---|---|---|
| Number | 24/45 (53%) | 21/45 (47%) | NA |
| Breed | 22 Mixed (92%) | 19 Mixed (91%) | NS |
| 2 Purebred (8%) | 2 Purebred (9%) | ||
| Sex | 16 M (67%) | 7 M (33%) | <.03 |
| 8 F (33%) | 14 F (67%) | ||
| Age, median (IQR), mo | 32 (12‐53) | 99 (9‐173) | <.04 |
| Duration of signs, median (IQR), d | 21 (1‐135) | 150 (2‐720) | NS |
| Other neurologic signs | 13 (54%) | 3 (17%) | <.01 |
| Creatinine, median (IQR), mg/dL | 1.2 (1.0‐1.4) | 1.5 (1.3‐2.2) | <.01 |
| USG, median (IQR) | 1.046 (1.031‐1.054) | 1.047 (1.023‐1.056) | NS |
| Urine culture positive | 5/14 (36%) | 6/14 (43%) | NS |
| Favorable outcome | 8/22 (36%) | 11/16 (69%) | NS |
Abbreviations: F, female; IQR, interquartile range; M, male; NA, not applicable; NS, not significant; USG, urine specific gravity.
Figure 1.

Frequency distribution of 45 cats with urinary incontinence by age group (juvenile 0‐6 months, young adult 6‐78 months, mature adult 79‐174 months, and geriatric >174 months) and by phase of micturition affected (voiding phase, dark gray bar; storage phases, and light gray bar)
When classified by anatomic localization, univariate analyses indicated that urethral disease was significantly more common in male cats (Table 3; P < .04). Cats with bladder disorders were significantly older than those in other anatomic groups (Table 3; P < .01). The proportion of spinal cord disease cats with other concomitant neurologic signs (loss of tail tone or sensation, caudal paresis or paralysis, or fecal incontinence) was significantly higher than cats with urethral or bladder disorders (P < .001). The limited numbers of cats with comorbid conditions in other anatomic groups precluded statistical analyses. No significant differences were found between anatomic groups for breed, body weight, duration of clinical signs, and serum biochemistry, urinalysis, and urine culture results.
Table 3.
Demographic features, clinicopathologic findings, and clinical outcomes for 45 cats with urinary incontinence categorized by anatomic lesion localization
| Feature | Spinal cord | Bladder | Urethra | Ureter | P‐value |
|---|---|---|---|---|---|
| Number | 18/45 (40%) | 9/45 (20%) | 17/45 (38%) | 1/45 (2%) | NA |
| Sex | 8 M (44%) | 2 M (22%) | 17 M (67%) | 0 M (0%) | <.04 |
| 10 F (56%) | 7 F (78%) | 8 F (33%) | 1 F (100%) | ||
| Breed | 16 Mixed (89%) | 7 Mixed (78%) | 17 Mixed (100%) | 1 Mixed (100%) | NS |
| 2 Purebred (11%) | 2 Purebred (22%) | 0 Purebred (0%) | Purebred (0%) | ||
| Age, median (IQR), mo | 35 (7‐86) | 174 (90‐199) | 29 (8‐82) | 34 (NA) | <.01 |
| Duration of signs, median (IQR), d | 22 (1‐198) | 21.5 (1‐112.5) | 105 (10.3‐180) | 920 (NA) | NS |
| Other neurologic signs | 15 (83%) | 1 (11%) | 3 (18%) | 0 (0%) | <.001 |
| SCr, median (IQR), mg/dL | 1.3 (1.1‐1.4) | 1.5 (1.4‐2.3) | 1.2 (1.0‐1.4) | 2.2 (NA) | NS |
| USG, median (IQR) | 1.047 (1.024‐1.057) | 1.029 (1.019‐1.047) | 1.047 (1.034‐1.053) | 1.056 (NA) | NS |
| Urine culture positive | 2/9 (22%) | 2/5 (40%) | 6/13 (46%) | 1/1 (100%) | NS |
| Favorable outcome | 3/17 (18%) | 7/8 (88%) | 9/13 (69%) | NR | <.04 |
Abbreviations: F, female; IQR, interquartile range; M, male; NA, not applicable; NR, not reported; SCr, serum creatinine; USG, urine specific gravity.
Several therapeutic agents and treatment modalities were used for specific and symptomatic management of disorders causing UI and associated comorbid conditions (see Data S2, Supplemental Information). The most common pharmacologic agents used for treatment of the 24 cats with voiding phase disorders included antimicrobials (12), opioid analgesics (10), anxiolytic drugs (5), alpha‐1 adrenergic blockers (6), and bethanechol (4). The most common pharmacologic agents used for the 21 cats with storage phase disorders included antimicrobials (17), opioid analgesics (5), and phenylpropanolamine (5). Treatment with multiple modalities was common with 24/45 (53%) of affected cats receiving ≥3 different treatments. Of 21 cats treated with antimicrobials in which urine cultures were available, only 10 had confirmed bacterial UTI. Surgical interventions were performed in 8 voiding phase and 2 storage phase disorder cats (Data S2). Two cats also had tail amputations performed to facilitate hygiene. Some modalities were used exclusively to treat voiding phase disorder cats with spinal cord disease, including physical treatment, cold laser treatment, and daily at‐home bladder expression (Data S2).
Outcomes were available for 38 cases. Nineteen cats (50%) had favorable outcomes with 16 regaining complete continence and 3 improving with treatment. Conditions associated with complete recovery included spinal cord trauma (3), feline idiopathic cystitis (FIC) (3), bacterial cystitis (2), ureteral stent (1), undetermined bladder dysfunction (1), urethritis (3), urethral stricture (2), and congenital USMI (1). Conditions associated with favorable, but incomplete, responses to treatment included congenital USMI (1), acquired USMI (1), and post‐urethrostomy urethral stricture (1). The remaining 19 cats (50%) had unfavorable outcomes (no improvement) including 11 cats that were euthanized. Conditions associated with unfavorable responses to treatment included spinal trauma (6), congenital spinal malformations (3), spinal neoplasia (2), intervertebral disk disease (2) fibrocartilaginous embolism (1), bladder neoplasia (1), urethral stricture (1), urethral hypoplasia (1), post‐perineal urethrostomy (1), and prostatic neoplasia (1). Results of the stepwise backward multivariable regression analysis of major risk factors indicated that anatomic site was the only significant predictor of unfavorable outcome (P = .03; Table 4). The second logistic regression analysis was performed to determine the influence of anatomic site on outcome. No significant increase in the risk of an unfavorable outcome was observed if the lesion localized to the bladder or urethra (P = .32). However, spinal cord lesions were 2.67 times more likely to have an unfavorable outcome compared to urethral or bladder lesions (Table 5).
Table 4.
Influence of major risk factors on the outcome (favorable or unfavorable) in 45 cats with urinary incontinence
| Risk factor | OR | CI | Prob > ChiSq |
|---|---|---|---|
| Anatomic site | 0.030 | 0.002‐0.350 | .0324 |
| Sex | 2.357 | 0.640‐8.676 | .1928 |
| Treatment | 1.339 | 0.297‐6.020 | .2883 |
| Age categorya | … | … | .4915 |
| Phase of micturition | 0.259 | 0.066‐1.020 | .5208 |
| Other neurological signs | 0.109 | 0.023‐0.513 | .6829 |
| UTIa | … | … | .7645 |
Unable to calculate OR because of insufficient data.
Table 5.
Influence of anatomical site on unfavorable outcome in 45 cats with urinary incontinence
| Site of the lesion | Odds ratio (CI) | Increase risk |
|---|---|---|
| Urethra | … | … |
| Bladder | 3.11 (0.281‐34.41) | … |
| Spinal cord | 0.095 (0.017‐0.529) | 2.67 |
4. DISCUSSION
Unlike dogs, studies describing the causes, treatments, and outcomes of cats with UI have largely been limited to case reports or case series focused primarily on congenital causes20 or cases in which trauma was excluded.54 To our knowledge, ours is the first comprehensive study characterizing the proportional morbidity of causes and outcomes of treatment associated with various causes of UI in cats. In our series of cats, UI was associated with a variety of congenital and acquired disorders that affected both phases of micturition with similar frequency. The proportional morbidity of causes, sex, age distribution, and outcomes of UI in our series of cats differed substantially from previous reports of UI in cats5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 and dogs.1, 61, 62, 63, 64, 65 Our observations indicated that spinal cord disorders were a common cause of UI in cats and were associated with less favorable outcomes compared to bladder and urethral disorders. Conversely, urethral and bladder disorders were associated with more favorable outcomes.
In our study, UI occurred with equal frequency between male and female cats. Voiding phase versus storage phase disorders also occurred with similar frequency. However, voiding phase disorders were significantly more common in male cats, whereas storage phase disorders were more common in female cats. This finding contrasts with that in dogs, in which UI is more commonly observed in females and usually is associated with storage phase disorders such as acquired USMI and congenital ureteral ectopia.1, 61, 62, 63, 64, 65 The reason for this disparity in the prevalence of causes of UI between dogs and cats is not completely understood, but may be related to species differences in urethral morphology and its effects on urethral mechanics for continence and micturition. Morphometric studies have shown that the feline urethra has more longitudinal smooth muscle and a narrower relative urethral lumen compared to dogs, resulting in twice the resistance to flow in the feline versus the canine urethra.66, 67 Furthermore, it has been hypothesized that the relatively longer internal urethral sphincter of the cat requires longitudinal smooth muscle contraction to actively shorten the urethra to facilitate sphincter opening.66, 67, 68 Consequently, urethral disorders in cats may be less likely to be associated with UI.
4.1. Spinal cord disease
When classified by anatomic site, spinal cord disease was identified in 18 of 45 (40%) incontinent cats and was the most common diagnosis associated with UI in our case series. In contrast, acquired or congenital urethral disorders were common causes of UI in dogs. In a study of 563 incontinent dogs,1 only 9 (2%) were classified as having neurogenic incontinence. In our group of cats with spinal cord disease, incontinence was associated with trauma in 9 of 18 (50%) cats. Clinical findings in the majority of cats with trauma‐induced spinal cord injury (8 of 9) were consistent with sacrococcygeal injury and cauda equina syndrome. Cauda equina syndrome is described in cats,69, 70, 71, 72, 73, 74, 75 dogs,76, 77, 78, 79 and humans81, 82, 83 as sensory or motor dysfunction or both resulting from injury to the terminal portion of the spinal cord and associated nerve roots. Clinical signs depend on the extent of injury to the spinal cord and peripheral nervous system and may include lumbosacral pain, tail analgesia and paralysis, fecal and UI, obstipation, pelvic limb paresis, and paresthesia.69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83 The spectrum of clinical findings associated with sacrococcygeal injury and cauda equina syndrome is related to the fact that, in cats, the spinal cord generally extends to the last lumbar or first sacral vertebra69, 70, 84 and the cauda equina extends to the first coccygeal vertebra.70, 78, 84, 85 Urinary incontinence and other micturition abnormalities have been reported with cauda equina syndrome in cats.10, 71, 73, 74, 75
Other spinal cord disorders observed in our series of incontinent cats included spinal cord neoplasia,14, 18 intervertebral disk disease (IVDD),8, 9 fibrocartilaginous embolism,17 spinal dysraphism,11, 12 and vertebral malformations,10 and have been reported previously. Importantly, results of our multivariable analyses indicated that spinal cord diseases were significantly more likely to be associated with an unfavorable outcome compared to urethral or bladder disorders. Furthermore, of the 11 cats that were euthanized, 8 had spinal cord lesions, and 3 of these cats were euthanized within 72 hours of initial presentation. Although the reasons for owners electing euthanasia are unknown, it is likely that the magnitude and extent of neurologic dysfunction, presence of other concomitant injuries or disorders, persistent incontinence despite treatment, and expense of treatment influenced owner decisions. Our observations suggest that UI associated with spinal cord disorders in cats warrants a guarded prognosis. In a previous retrospective study of 51 cats with traumatic sacrococcygeal injury, temporary or permanent UI was observed in 37 (73%) cats.73 However, the prognosis for return of normal urinary function was good in cats with intact anal tone and perineal sensation on presentation. Return to normal urination occurred within 2 and 30 days, with a mean of 13 days; every cat that was unable to urinate normally by 30 days remained incontinent. Cats with tail flaccidity and urine retention on presentation had a very poor prognosis for recovery normal urinary function.
4.2. Congenital disease
Congenital abnormalities accounted for only 18% of our series of incontinent cats and included 4 cats with congenital spinal canal malformations (eg, Manx syndrome or spinal dysraphism),11, 12 1 cat with bilateral ureteral ectopia,20, 21, 22, 23 2 cats with presumed congenital USMI,20, 30, 39 and 1 cat with urethral hypoplasia.20, 53 These and other congenital causes of UI in cats have been reported previously.19, 23, 27, 33, 46, 86, 87, 88 It is difficult to draw conclusions on the proportional morbidity of congenital disorders in our series of cats because of relatively small numbers of affected cats and the fact that previous studies rarely reported congenital spinal cord diseases. In a previous study of 19 cats with congenital UI, 10 cats had ureteral ectopia and 9 had USMI and urethral hypoplasia.20 However, that study included only cases of congenital ureteral ectopia and USMI or urethral hypoplasia, and did not include other causes of congenital UI, such as congenital spinal cord malformations10, 11, 12 or other congenital urinary tract abnormalities.86, 87, 88 When compared to dogs, the prevalence of congenital causes of UI in our series of cats was approximately one‐half of that reported in canine populations.1 In a study of 563 dogs with UI, 226 (38%) were diagnosed with congenital causes of UI including ureteral ectopia, congenital USMI, or intersex disorders.1 Similar to surveys in cats, however, congenital causes of neurogenic incontinence in these dogs were not reported. The reason for this disparity between species is not fully understood but may be related to relative differences in the prevalence of ureteral ectopia in their respective populations. Although very rare in cats, ureteral ectopia is a common cause of UI in juvenile dogs.1, 87, 88 In 1 study, ureteral ectopia accounted for >50% of cases of congenital UI in dogs.1 Additional studies of larger populations of cats are needed to better characterize differences in the prevalence of congenital disorders causing UI in dogs and cats.
4.3. Urethral disease
Urethral disorders were identified in 17 cats and represented the second most common anatomic category of causes of UI in our series. Diagnoses included urethral stricture, urethral stents, urethritis, congenital and acquired USMI, congenital urethral hypoplasia, post‐perineal urethrostomy, and undetermined urethral dysfunction, all of which have been reported previously.20, 29, 30, 39, 41, 42, 44, 47, 50 Other reported urethral disorders associated with UI in cats include urethral diverticulum,46 prostatitis,48 prostatic neoplasia,40 reflex dyssynergia,29, 43, 45 and epidural analgesia.49 Urethral diseases were significantly more common in males, most likely because of increased frequency of iatrogenic injury occurring secondary to perineal urethrostomy (5 cats) or urethral catheterization (2 cats), which has been reported previously.44, 89 Outcomes were available for 13 cats and multivariable analyses indicated that urethral diseases had a higher likelihood of favorable outcome compared to spinal cord disease, with complete resolution or improvement observed in 69% of cats with urethral disease. A more favorable prognosis most likely reflected a higher prevalence of reversible or more readily treatable disorders (eg, urethral strictures, urethritis, congenital, or acquired USMI) in this disease category.
4.4. Urinary bladder disease
Urinary bladder disorders were identified in 9 cats with UI and included both storage and voiding phase disorders. Diagnoses included inflammation‐associated detrusor dysfunction (6 cats), neoplasia (1 cat), and detrusor dysfunction of undetermined cause (2 cats). All cats with inflammation‐associated detrusor dysfunction had a concurrent inflammatory storage phase disorder associated with small bladders and other lower urinary tract signs including pollakiuria, stranguria, or periuria. Not surprisingly, UI resolved in these cats with elimination or remission of the concurrent inflammatory disorder. Although it is tempting to presume that these cats had urge incontinence, it is difficult to determine whether UI in these cats was caused by urge incontinence or some other cause of bladder instability or hyperreflexia. In people, urgency UI is the complaint of involuntary leakage accompanied by or immediately preceded by urgency.90, 91, 92 Causes of urge incontinence in people include motor urgency (bladder overactivity), sensory urgency (eg, inflammation associated with UTI, urolithiasis, interstitial cystitis/painful bladder syndrome), neuropathic bladder dysfunction, urethral instability, and idiopathic disease.90, 91, 92 In veterinary medicine, no clear consensus has been established for the definition of urge incontinence. In cats, urge incontinence has been defined as the inability to control micturition between the time of the urge to urinate and actual voiding and is characterized by urinary tract inflammation, loss of bladder compliance, and small bladder capacity.55
In our series, inflammation‐associated storage phase incontinence was observed in 3 cats diagnosed with FIC, 2 cats with UTI, and in 1 cat after placement of a ureteral stent and SC ureteral bypass (SUB) device to treat bilateral ureteral obstruction. Urge incontinence has been reported by others in cats with UTI,29 FIC,29, 59 urolithiasis,28 bladder neoplasia,35 and idiopathic detrusor instability.32 However, to our knowledge, ours is the first report of incontinence associated with ureteral stent and SUB placement, although dysuria has been reported with these implants.93, 94 Idiopathic cystitis is a common lower urinary tract disorder of primarily young to middle‐aged cats that is characterized by periuria, dysuria, pollakiuria, stranguria, and macroscopic hematuria.95, 96, 97 In our series of cats with FIC, all had pollakiuria, hematuria, periuria, and dysuria in addition to UI. The specific behaviors described by owners related to UI included dribbling of urine, involuntarily voiding urine while at rest, and episodes of hemorrhagic urine discharge. In all cases, UI resolved completely with concomitant resolution of other lower urinary tract signs. Although FIC occurs commonly in cats, there are only anecdotal reports of UI secondary to FIC.26, 59 The lack of previous reports of UI secondary to FIC may simply be a consequence of the relatively low prevalence of UI as a sign of FIC.95, 96, 97, 98 Nevertheless, FIC should be considered as a differential diagnosis in all cats presenting with UI, especially those with concomitant lower urinary tract signs of cystitis in which UTI, neoplasia, and urolithiasis have been ruled out.
Overall, cats with bladder disease had the highest frequency of favorable outcome, with 88% cats having complete recovery of urinary continence. This finding is not unexpected because a majority of these cats had diseases that are easily treatable (eg, bacterial cystitis), or are in many cases self‐limiting and likely to resolve in time with little or no treatment (eg, acute nonobstructive FIC).96, 97, 98, 99, 100
4.5. Comorbid conditions‐UTI
Urinary tract infection was detected commonly across all categories, occurring in 11 of 28 (39%) cats in which urine cultures were available. Bacterial UTI was detected with similar frequency among cats with voiding phase versus storage phase disorders. Bacterial UTI appeared to be a primary cause of UI in 3 cats with inflammation‐associated incontinence, whereas UTI appeared to be a sequala of UI in the remaining cases. Although common, results of univariate and multivariable analyses indicated that UTI was not significantly associated with outcome. In a case‐control study of 155 cats with UTI, UI was the strongest risk factor for developing UTI in cats.101 Mechanisms that may favor development of UTI in incontinent cats include urine retention because of detrusor muscle areflexia or partial urethral obstruction for voiding phase disorders, or urine pooling or staining for storage phase disorders, resulting in a persistently wet perineum and an increased skin bacterial population, which may allow bacteria to ascend through the urethra and colonize the urinary bladder.101, 102, 103
4.6. Treatments
A variety of therapeutic interventions were attempted; the majority (53%) of cats received >3 treatments. Because of the large number of therapeutic modalities employed, it is difficult to assess the impact of any single treatment on outcome. Whereas half of the cats undergoing surgery for a potentially reversible lesion had favorable outcomes, multivariable analyses indicated that surgery in combination with medical management was not associated with more favorable outcomes compared with medical management alone. However, this observation should be viewed cautiously. Based on limited sample size and inability to control for other concomitant treatments, we cannot exclude the possibility of type II statistical error. Similarly, insufficient numbers of cats treated with other specific medical modalities precluded statistical analysis.
It is noteworthy that none of the cats treated with the alpha‐adrenergic drug phenylpropanolamine in which follow‐up was available (5 of 6 cats) were reported to have responded favorably to the medication. Four of these cats were classified as having storage phase disorders (2 with congenital USMI, 1 with acquired USMI, and 1 with a transitional L7 vertebra); 1 cat was classified as having a voiding phase disorder (cauda equina syndrome). Poor responses to phenylpropanolamine similarly were observed by others in 3 cats with congenital USMI39 and in 2 cats with urethral insufficiency after perineal urethrostomy, that showed no improvement in clinical signs or urethral pressure profiles with phenylpropanolamine administration.29 However, other reports have described more favorable responses to phenylpropanolamine including a cat with UI caused by feline leukemia‐related myelopathy54 and a kitten with genitourinary dysplasia that improved dramatically after reconstructive surgery and became fully continent when phenylpropanolamine was administered.53 In contrast to cats, phenylpropanolamine has a high rate of clinical success in female dogs with acquired USMI, with continence rates of 85 to 90% after 28 days of treatment.104, 105, 106 Similar controlled studies investigating the safety and efficacy of phenylpropanolamine for treatment of UI in cats have not been reported. The reason for this apparent species disparity in response to phenylpropanolamine is unknown. It is possible that morphometric differences in feline versus canine urethral smooth muscle results in decreased responsiveness to the effects of phenylpropanolamine in cats.66, 67 However, proof of this hypothesis requires further investigation.
4.7. Limitations
Our study had several limitations, predominantly because of its retrospective nature and the diversity of causes and treatments encountered in our population of cats. Some reported causes of UI were not represented in our study, such as dysautonomia,36 UI secondary to FeLV,5 bladder torsion,31 and various genitourinary congenital abnormalities.51, 52, 53 Diagnostic testing was performed in each case at the discretion of the clinician, and no standardized diagnostic protocol was followed. Unless involuntary urine leakage was observed on physical examination (as it was in some, but not all cases), owner observations often were used as a primary means of diagnosing UI. Owners may not have been aware that UI is a passive process or may have mischaracterized other abnormal voiding behaviors such as pollakiuria or periuria as incontinence. Similarly, owner‐reported behaviors of urgency (stranguria, pollakiuria, periuria) also were used to define inflammation‐associated detrusor dysfunction in cats with storage phase UI. To minimize the risk of misdiagnosis, the owner's history was carefully reviewed in each case by the authors to identify other descriptors (eg, urine leakage, dribbling, bloody urine discharge, wet bedding, or soiling of owner's clothing while resting) that would be consistent with a diagnosis of UI.
Although outcomes were available for most cats, follow‐up information was obtained from owners or primary care veterinarians at variable time periods after diagnosis and treatment. In addition, all cats did not undergo a standardized comprehensive evaluation. Although these limitations could result in misclassification error, all cats included in the study were deemed to have sufficient data to determine functional and anatomic classifications. Unfortunately, the number and diversity of disorders and the fact that management often involved multiple treatments, largely precluded assessment of the impact of individual treatments on outcome. Consequently, we chose to limit assessment of treatment to 2 broad categories of medical management with or without surgery. Doing so allowed assessment of potential confounding of surgical disorders or interventions on outcome. Although no significant effect was identified, the relatively small sample size for each disease in the treatment category increased the risk of type II statistical error. Additional studies are needed to evaluate the effect of disease processes as well as specific treatment on outcome. However, because of the low prevalence of UI in cats in our population (only 0.2% of cases over 11 years), larger multicenter studies likely would be required to achieve timely collection of adequate sample size.
5. CONCLUSION
In summary, results of our study indicate that the proportional morbidity of the causes of UI in cats differs substantially from that of dogs. Spinal cord disorders were the most common cause of UI in our series of cats and were more likely to have an unfavorable outcome compared to bladder and urethral disorders. Conversely, urethral and bladder disorders, especially those causing urgency incontinence, were associated with more favorable outcomes. A large number of therapeutic agents and modalities were used for management of UI in our series of cats. However, because of the diversity of disorders and number of therapeutic agents involved, it was difficult to assess the efficacy of any single agent. The uncertainly surrounding optimal management of UI in cats is compounded by the lack of controlled studies investigating the efficacy and safety of treatments used for cats with UI. Future large‐scale clinical studies will be necessary to further characterize the causes of UI cats and identify safe and effective management strategies.
CONFLICT OF INTEREST DECLARATION
Authors declare no conflict of interest.
OFF‐LABEL ANTIMICROBIAL DECLARATION
Authors declare no off‐label use of antimicrobials.
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) OR OTHER APPROVAL DECLARATION
Authors declare no IACUC or other approval was needed.
HUMAN ETHICS APPROVAL DECLARATION
Authors declare human ethics approval was not needed for this study.
Supporting information
Data 1: Search Terms
Data 2. Therapeutic agents used for management of 45 cats with urinary incontinence and associated comorbid conditions.
ACKNOWLEDGMENTS
The authors acknowledge Luann Longstreth RHIT for her assistance with medical record data retrieval. Portions of this work were presented in poster form at the 2018 ACVIM Forum, Seattle, WA.
Lonc KM, Kaneene JB, Carneiro PAM, Kruger JM. Retrospective analysis of diagnoses and outcomes of 45 cats with micturition disorders presenting as urinary incontinence. J Vet Intern Med. 2020;34:216–226. 10.1111/jvim.15683
Funding information Michigan State University Center for Feline Health and Well Being
Present address Kaitlin M. Lonc, Oakland Veterinary Referral Services, 1400 S Telegraph Rd, Bloomfield Township, MI 48302.
REFERENCES
- 1. Holt PE. Urinary incontinence in dogs and cats. Vet Rec. 1990;127:347‐350. [PubMed] [Google Scholar]
- 2. Lekcharoensuk C, Osborne CA, Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc. 2001;218:1429‐1435. [DOI] [PubMed] [Google Scholar]
- 3. Lulich JP, Osborne CA, Bartges JW, et al. Canine lower urinary tract disorders In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 4th ed. Philadelphia, PA: WB Saunders; 1995:1833‐1861. [Google Scholar]
- 4. Bartges JW. Lower urinary tract disease in geriatric cats. Paper presented at: Proceedings 15th Annual ACVIM Forum, Lake Buena Vista, FL; 1997;322‐324.
- 5. Carmichael KP, Bienzle D, McDonnell JJ. Feline leukemia virus–associated myelopathy in cats. Vet Pathol. 2002;39:536‐545. [DOI] [PubMed] [Google Scholar]
- 6. Child G, Foster DJ, Fougere BJ, Milan JM, Rozmanec M. Ataxia and paralysis in cats in Australia associated with exposure to an imported gamma‐irradiated commercial dry pet food. Aust Vet J. 2009;87:349‐351. [DOI] [PubMed] [Google Scholar]
- 7. Foley JE, Lapointe JM, Koblik P, Poland A, Pedersen NC. Diagnostic features of clinical neurological feline infectious peritonitis. J Vet Intern Med. 1998;12:415‐423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Harris JE, Dhupa S. Lumbosacral intervetebral disk disease in six cats. J Am Anim Hosp Assoc. 2008;44:109‐115. [DOI] [PubMed] [Google Scholar]
- 9. Muñana KR, Olby NJ, Sharp NJH, et al. Intervertebral disk disease in 10 cats. J Am Anim Hosp Assoc. 2001;37:384‐389. [DOI] [PubMed] [Google Scholar]
- 10. Hurov L. Laminectomy for treatment of cauda equine syndrome in a cat. J Am Vet Med Assoc. 1985;186:504‐505. [PubMed] [Google Scholar]
- 11. James CCM, Lassman LP, Tomlinson BE. Congenital anomalies of the lower spine and spinal cord in Manx cats. J Pathol. 1969;97:269‐276. [DOI] [PubMed] [Google Scholar]
- 12. DeForest ME, Basrur PK. Malformations and the Manx syndrome in cats. Can Vet J. 1979;20:304‐314. [PMC free article] [PubMed] [Google Scholar]
- 13. Matres‐Lorenzo L, Bernardé A, Bernard F. Video‐assisted removal of metal pellet fragments from the vertebral canal following gunshot injury and long‐term outcome in a cat. Vet Comp Orthop Traumatol. 2016;29:439‐443. [DOI] [PubMed] [Google Scholar]
- 14. Northington JW. Metrizamide myelography in five dogs and two cats with suspected spinal cord neoplasms. Vet Rad. 1980;21:149‐155. [Google Scholar]
- 15. Parent JM, Isler C, Holmberg DL, et al. Intramedullary spinal glioblastoma in a cat, presented as a cauda equina syndrome. Can Vet J. 1982;23:169‐172. [PMC free article] [PubMed] [Google Scholar]
- 16. Schmidt MJ, Schachenmayr W, Thiel C, et al. Recurrent spinal arachnoid cyst in a cat. J Feline Med Surg. 2007;9:509‐513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Scott HW, O'Leary MT. Fibrocartilaginous embolism in a cat. J Small Anim Pract. 1996;37:228‐231. [DOI] [PubMed] [Google Scholar]
- 18. Spodnick GJ, Berg J, Moore FM, Cotter SM. Spinal lymphoma in cats: 21 cases (1976‐1989). J Am Vet Med Assoc. 1992;200:373‐376. [PubMed] [Google Scholar]
- 19. Tong T, Simpson DJ. Spinal dermoid sinus in a Burnese cat with paraparesis. Aust Vet J. 2009;87:450‐454. [DOI] [PubMed] [Google Scholar]
- 20. Holt PE, Gibbs C. Congenital urinary incontinence in cats: a review of 19 cases. Vet Rec. 1992;130:437‐442. [DOI] [PubMed] [Google Scholar]
- 21. Smith CW, Burke TJ, Froehlich P, Wright WH. Bilateral ureteral ectopia in a male cat with urinary incontinence. J Am Vet Med Assoc. 1983;182:172‐173. [PubMed] [Google Scholar]
- 22. Di Mauro FM, Singh A, Reynolds D, et al. Combined use of intravesicular ureteroneocystostomy techniques to correct ureteral ectopia in a male cat. J Am Anim Hosp Assoc. 2014;50:71‐76. [DOI] [PubMed] [Google Scholar]
- 23. Ghantous SN, Crawford J. Double ureters with ureteral ectopia in a domestic shorthair cat. J Am Anim Hosp Assoc. 2006;42:462‐466. [DOI] [PubMed] [Google Scholar]
- 24. Barrand KR. Rectal prolapsed associated with urinary bladder neoplasia in a cat. J Small Anim Pract. 1999;40:222‐223. [DOI] [PubMed] [Google Scholar]
- 25. Benigini L, Lamb CR, Corzo‐Menendez N, et al. Lymphoma affecting the urinary bladder in three dogs and a cat. Vet Radiol Ultrasound. 2006;47:592‐596. [DOI] [PubMed] [Google Scholar]
- 26. Chew DJ. Diagnosing and managing urinary incontinence in dogs. Paper presented at: Proceedings 2015 Virginia Veterinary Conference, Roanoke, VA; 2015.
- 27. Cook AB, Lanston CE, Fischetti AJ, Donovan TA. Imaging diagnosis—urinary bladder duplication in a cat. Vet Radiol Ultrasound. 2014;56:E48‐E53. [DOI] [PubMed] [Google Scholar]
- 28. Dear JD, Shiraki R, Ruby AL, Westropp JL. Feline urolithiasis: a retrospective study of 159 cases. J Feline Med Surg. 2011;13:725‐732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Gregory CR. Electromyographic and urethral pressure profilometry: clinical application in male cats. Vet Clin North Am Small Anim Pract. 1984;14:567‐574. [DOI] [PubMed] [Google Scholar]
- 30. Holt PE. Surgical management of congenital urethral sphincter mechanism incompetence in eight female cats and a bitch. Vet Surg. 1993;22:98‐104. [DOI] [PubMed] [Google Scholar]
- 31. James DR, Collins D, Johnson PJ, Marchevsky AM. Chronic urinary bladder torsion causing urinary incontinence in a cat. JFMS Open Rep. 2015;1:1‐5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Lappin MR, Barsanti JA. Urinary incontinence secondary to idiopathic detrusor instability: cystometrographic diagnosis and pharmacologic management in two dogs and a cat. J Am Vet Med Assoc. 1987;191:1439‐1442. [PubMed] [Google Scholar]
- 33. Laverty PH, Salisbury SK. Surgical management of true patent urachus in a cat. J Small Anim Pract. 2002;43:227‐229. [DOI] [PubMed] [Google Scholar]
- 34. Neville‐Towle J, Sakals S. Urinary bladder herniation through a caudoventral abdominal wall defect in a mature cat. Can Vet J. 2015;56:934‐936. [PMC free article] [PubMed] [Google Scholar]
- 35. Pavia PR, Havig ME, Donovan TA, Craft D. Malignant peripheral nerve sheath tumor of the urinary bladder in a cat. J Small Anim Pract. 2012;53:245‐248. [DOI] [PubMed] [Google Scholar]
- 36. Sharp NJH, Nash AS, Griffiths IR. Feline dysautonomia (the Key‐Gaskell syndrome): a clinical and pathological study of forty cases. J Small Anim Pract. 1984;25:599‐615. [Google Scholar]
- 37. Ruiz‐Drebing M, Yap F, Seth M, et al. Membrane‐like structure in the urinary bladder neck of a young cat: diagnosis and treatment using balloon dilatation and a balloon‐expandable metallic stent. JFMS Open Rep. 2017;3:1‐6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Wilson HM, Chun R, Larson VS, Kurzman ID, Vail DM. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004). J Am Vet Med Assoc. 2007;231:101‐106. [DOI] [PubMed] [Google Scholar]
- 39. Wilson KE, Berent AC, Weisse CW. Use of percutaneously controlled hydraulic occluder for treatment of refractory urinary incontinence in three female cats. J Am Vet Med Assoc. 2016;248:544‐551. [DOI] [PubMed] [Google Scholar]
- 40. Carpenter J, Andrews L, Holsworth J. Tumors and tumor‐like lesions In: Holzworth J, ed. Diseases of the Cat. Philadelphia, PA: WB Saunders; 1987:406‐496. [Google Scholar]
- 41. Berzon JL. Complications of elective ovariohysterectomies in the dog and cat at a teaching institution: clinical review of 853 cases. Vet Surg. 1979;8:89‐91. [Google Scholar]
- 42. Brace MA, Weisse C, Berent A. Preliminary experience with stenting for management of non‐urolith urethral obstruction in eight cats. Vet Surg. 2014;43:199‐208. [DOI] [PubMed] [Google Scholar]
- 43. Chew DJ, Buffington CAT, Kendall MS, et al. Urethroscopy, cystoscopy, and biopsy of the feline lower urinary tract. Vet Clin N Am Small Anim Pract. 1996;26:441‐462. [DOI] [PubMed] [Google Scholar]
- 44. Corgozinho KB, de Souza HJM, Pereira AN, et al. Catheter‐induced urethral trauma in cats with urethral obstruction. J Feline Med Surg. 2007;9:481‐486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Filippich LJ, Read RA, Riesz G. Functional urethral obstruction in a cat. Aust Vet Pract. 1989;19:202‐206. [Google Scholar]
- 46. Foster SF, Hunt GB, Malik R. Congenital urethral anomaly in a kitten. J Feline Med Surg. 1999;1:61‐64. [DOI] [PubMed] [Google Scholar]
- 47. Phillips H, Holt DE. Surgical revision of the urethral stoma following perineal urethrostomy in 11 cats: (1998‐2004). J Am Anim Hosp Assoc. 2006;42:218‐222. [DOI] [PubMed] [Google Scholar]
- 48. Pointer E, Murray L. Chronic prostatitis, cystitis, pyelonephritis, and balanoposthitis in a cat. J Am Anim Hosp Assoc. 2011;47:258‐261. [DOI] [PubMed] [Google Scholar]
- 49. Song RB, Cross JR, Golder FJ, Callan MB. Suspected epidural morphine analgesia induced chronic urinary and bowel dysfunction in a cat. J Feline Med Surg. 2011;13:602‐605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Pisu MC, Veronesi MC. Effectiveness of deslorelin acetate subcutaneous implantation in a domestic queen with after‐spaying urinary incontinence. J Feline Med Surg. 2014;16:366‐368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Allen WE, Webbon PM. Two cases of urinary incontinence in cats associated with acquired vagino‐ureteral fistula. J Small Anim Pract. 1980;21:367‐371. [DOI] [PubMed] [Google Scholar]
- 52. Jones AK. Unusual case of feline incontinence. Vet Rec. 1983;112:555. [DOI] [PubMed] [Google Scholar]
- 53. Baines SJ, Speakman AJ, Williams JM, Cheeseman MT. Genitourinary dysplasia in a cat. J Small Anim Pract. 1999;40:286‐290. [PubMed] [Google Scholar]
- 54. Barsanti JA, Downey R. Urinary incontinence in cats. J Am Anim Hosp Assoc. 1984;20:979‐982. [Google Scholar]
- 55. Barsanti JA, Finco DR. Feline urinary incontinence In: Kirk RW, ed. Current Veterinary Therapy, Small Animal Practice IX. Philadelphia, PA: WB Saunders; 1986:1159‐1163. [Google Scholar]
- 56. Byron JK. Micturition disorders. Vet Clin Small Anim. 2015;45:769‐782. [DOI] [PubMed] [Google Scholar]
- 57. Fisher J, Lane I. Micturition disorders In: Bartges J, Polzin D, eds. Nephrology and Urology of Small Animals. Ames, IA: Blackwell Publishing; 2011:755‐777. [Google Scholar]
- 58. Kornegay JN. Paraparesis (paraplegia), tetraparesis (tetraplegia), urinary/fecal incontinence. Spinal cord diseases. Probl Vet Med. 1991;3:363‐377. [PubMed] [Google Scholar]
- 59. Labato MA, Aciero MJ. Micturition disorders and urinary incontinence In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Elsevier; 2010:160‐164. [Google Scholar]
- 60. Hoyumpa Vogt A, Rodan I, Brown M, et al. AAFP‐AAHA: feline life stage guidelines. J Feline Med Surg. 2010;12(1):43‐54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Holt PE. Urinary incontinence in the bitch due to sphincter mechanism incompetence: prevalence in referred dogs and retrospective analysis of sixty cases. J Small Anim Pract. 1985;26:181‐190. [Google Scholar]
- 62. Thrusfield MV, Holt PE, Muirhead RH. Acquired urinary incontinence in bitches: its incidence and relationship to neutering practices. J Small Anim Pract. 1998;39:559‐566. [DOI] [PubMed] [Google Scholar]
- 63. Hall JL, Owen L, Church DB, et al. Urinary incontinence in male dogs under primary veterinary care in England: prevalence and risk factors. J Small Anim Pract. 2018;60:86‐95. [DOI] [PubMed] [Google Scholar]
- 64. O'Neill DG, Riddell A, Church DB, et al. Urinary incontinence in bitches under primary veterinary care in England: prevalence and risk factors. J Small Anim Pract. 2017;58:685‐693. [DOI] [PubMed] [Google Scholar]
- 65. Aaron A, Eggleton K, Power C, Holt PE. Urethral sphincter mechanism incompetence in male dogs: a retrospective analysis of 54 cases. Vet Rec. 1996;139:542‐546. [DOI] [PubMed] [Google Scholar]
- 66. Cullen WC, Fletcher T, Bradley WF. Morphometry of the male feline pelvic urethra. J Urol. 1983;129:186‐189. [DOI] [PubMed] [Google Scholar]
- 67. Cullen WC, Fletcher T, Bradley WF. Morphometry of the female feline pelvic urethra. J Urol. 1983;129:190‐192. [DOI] [PubMed] [Google Scholar]
- 68. Abdel‐Rahman M, Galeano C, Lamarche J, Elhilali MM. A new approach to the study of the voiding cycle in the cat. Invest Urol. 1981;18:475‐478. [PubMed] [Google Scholar]
- 69. Indrieri RJ. Lumbosacral stenosis and injury of the cauda equina. Vet Clin Small Anim. 1988;18:697‐710. [DOI] [PubMed] [Google Scholar]
- 70. Eminaga S, Palus V, Cherubini GB. Acute spinal cord injury in the cat. J Feline Med Surg. 2011;13:850‐862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Moise NS, Flanders JA. Micturition disorders in cats with sacrocaudal vertebral lesions In: Kirk RW, ed. Current Veterinary Therapy VIII Small Animal Practice. Philadelphia, PA: WB Saunders; 1983:722‐726. [Google Scholar]
- 72. Cariou MP, Störk CK, Petite AF, Rayward RM. Cauda equina syndrome treated by lumbosacral stabilisation in a cat. Vet Comp Orthop Traumatol. 2008;21:462‐466. [DOI] [PubMed] [Google Scholar]
- 73. Smeak DD, Olmstead ML. Fracture/luxation of the sacrococcygeal area in the cat, a retrospective study of 51 cases. Vet Surg. 1985;14:319‐324. [Google Scholar]
- 74. Tatton B, Jeffery N, Holmes M. Predicting recovery of urination control in cats after Sacrocaudal injury: a prospective study. J Small Anim Pract. 2009;50:593‐596. [DOI] [PubMed] [Google Scholar]
- 75. Anderson A, Coughlan AR. Sacral fractures in dogs and cats: a classification scheme and review of 51 cases. J Small Anim Pract. 1997;38:404‐409. [DOI] [PubMed] [Google Scholar]
- 76. Berzon JL, Dueland R. Cauda equina syndrome: pathophysiology and report of seven cases. J Am Anim Hosp Assoc. 1979;15:635. [Google Scholar]
- 77. Slocum B, Devine T. L7‐S1 fixation‐fusion for treatment of cauda equina compression in the dog. J Am Vet Med Assoc. 1986;188:31‐35. [PubMed] [Google Scholar]
- 78. Flückiger MA, Damur‐Djuric N, Hässig M, et al. A lumbosacral transitional vertebra in the dog predisposes to cauda equina syndrome. Vet Radiol Ultrasound. 2006;47:39‐44. [DOI] [PubMed] [Google Scholar]
- 79. De Risio L, Thomas WB, Sharp NJH. Degenerative lumbosacral stenosis. Vet Clin Small Anim. 2000;30:111‐132. [DOI] [PubMed] [Google Scholar]
- 80. Orendácová J, Cízková D, Kafka J, et al. Cauda equina syndrome. Prog Neurobiol. 2001;64:613‐637. [DOI] [PubMed] [Google Scholar]
- 81. Kusakabe T. Cauda equina syndrome. Orthop Trauma. 2013;27:215‐219. [Google Scholar]
- 82. Harrop JS, Hunt GE Jr, Vaccaro AR. Conus medullaris and cauda equina syndrome as a result of traumatic injuries: management principles. Neurosurg Focus. 2004;16:19‐23. [DOI] [PubMed] [Google Scholar]
- 83. Todd NV, Dickson RA. Standards of care in cauda equina syndrome. Br J Neurosurg. 2016;30:518‐522. [DOI] [PubMed] [Google Scholar]
- 84. Dyce KM, Sack WO, Wensing CJG. Textbook of Veterinary Anatomy. 4th ed. St. Louis, MO: Saunders; 2010. [Google Scholar]
- 85. Valverde A. Epidural analgesia and anesthesia in dogs and cats. Vet Clin Small Anim. 2008;38:1205‐1230. [DOI] [PubMed] [Google Scholar]
- 86. Kruger JM, Osborne CA, Lulich JP, Oakley RE. Inherited and congenital diseases of the feline lower urinary tract. Vet Clin Small Anim. 1996;26:265‐279. [PubMed] [Google Scholar]
- 87. Bartges JW, Callens AJ. Congenital diseases of the lower urinary tract. Vet Clin Small Anim. 2015;45:703‐719. [DOI] [PubMed] [Google Scholar]
- 88. Kruger JM, Bartges JW, Ballegeer EA, Bartges JW, Callens AJ. Congenital diseases of the lower urinary tract In: Ettinger SJ, Feldman EC, Cote E, eds. Textbook of Veterinary Internal Medicine. 7th ed. Philadelphia, PA: WB Saunders; 2017:2017‐2031. [Google Scholar]
- 89. Scavelli TD. Complications associated with perineal urethrostomy in the cat. Probl Vet Med. 1989;1:111‐119. [PubMed] [Google Scholar]
- 90. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub‐committee of the International Continence Society. Neurourol Urodyn. 2002;21:167‐178. [DOI] [PubMed] [Google Scholar]
- 91. Clemens JQ, Bogart LM, Liu K, Pham C, Suttorp M, Berry SH. Perceptions of “urgency” in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol Urodyn. 2011;30:402‐405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Swami SK, Abrams P. Urge incontinence. Urol Clin North Am. 1996;23:417‐425. [DOI] [PubMed] [Google Scholar]
- 93. Wormser C, Clarke DL, Aronson LR. Outcomes of ureteral surgery and ureteral stenting in cats: 117 cases (2006–2014). J Am Vet Med Assoc. 2016;248:518‐525. [DOI] [PubMed] [Google Scholar]
- 94. Berent AC, Weisse CW, Bagley DH, Lamb K. Use of a subcutaneous ureteral bypass device for treatment of benign ureteral obstruction in cats: 174 ureters in 134 cats (2009–2015). J Am Vet Med Assoc. 2018;253:1309‐1327. [DOI] [PubMed] [Google Scholar]
- 95. Kruger JM, Osborne CA, Lulich JP. Changing paradigms of feline idiopathic cystitis. Vet Clin Small Anim. 2008;39:15‐40. [DOI] [PubMed] [Google Scholar]
- 96. Defauw PA, Van de Maele I, Duchateau L, et al. Risk factors and clinical presentation of cats with feline idiopathic cystitis. J Feline Med Surg. 2011;13:967‐975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Kalkstein TS, Kruger JM, Osborne CA. Feline idiopathic lower urinary tract disease. Part I: clinical manifestations. Vet Clin Small Anim. 2008;39:15‐40. [Google Scholar]
- 98. Westropp JL, Delgado M, Buffington CAT. Chronic lower urinary tract signs in cats: current understanding of pathophysiology and management. Vet Clin Small Anim. 2019;49:187‐209. [DOI] [PubMed] [Google Scholar]
- 99. Kruger JM, Conway TS, Kaneene JB, et al. Randomized controlled trial of the efficacy of short‐term amitriptyline administration for treatment of acute, nonobstructive, idiopathic lower urinary tract disease in cats. J Am Vet Med Assoc. 2003;222:749‐758. [DOI] [PubMed] [Google Scholar]
- 100. Kruger JM, Lulich JP, MacLeay J, et al. Comparison of foods with differing nutritional profiles for long‐term management of acute nonobstructive idiopathic cystitis in cats. J Am Vet Med Assoc. 2015;247:508‐517. [DOI] [PubMed] [Google Scholar]
- 101. Martinez‐Ruzafa I, Kruger JM, Miller R, Swenson CL, Bolin CA, Kaneene JB. Clinical features and risk factors for development of urinary tract infections in cats. J Feline Med Surg. 2012;14:729‐740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Byron JK, Taylor KH, Phillips GS, Stahl MS. Urethral sphincter mechanism incompetence in 163 neutered female dogs: diagnosis, treatment, and relationship of weight and age at neuter to development of disease. J Vet Intern Med. 2017;31:442‐448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Stiffler KS, Stevenson MA, Sanchez S, et al. Prevalence and characterization of urinary tract infections in dogs with surgically treated type 1 thoracolumbar intervertebral disc extrusion. Vet Surg. 2006;35:330‐336. [DOI] [PubMed] [Google Scholar]
- 104. Scott L, Leddy M, Bernay F, Davot JL. Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch. J Small Anim Pract. 2002;43:493‐496. [DOI] [PubMed] [Google Scholar]
- 105. Richter KP, Ling GV. Clinical response and urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence. J Am Vet Med Assoc. 1985;187:605‐611. [PubMed] [Google Scholar]
- 106. White RA, Pomeroy CJ. Phenylpropanolamine: an alpha‐adrenergic agent for the management of urinary incontinence in the bitch associated with urethral sphincter mechanism incompetence. Vet Rec. 1989;125:478‐480. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data 1: Search Terms
Data 2. Therapeutic agents used for management of 45 cats with urinary incontinence and associated comorbid conditions.
